Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Cocrystal Pharma, Inc., formerly known as Bio...
September 21 2018 - 11:41AM
Business Wire
Federman & Sherwood announces that on September 20, 2018, a
class action lawsuit was filed in the United States District Court
for the District of New Jersey against Cocrystal Pharma, Inc.,
f/k/a BioZone Pharmaceuticals, Inc. (NASDAQ: COCP). The complaint
alleges violations of federal securities laws, Sections 10(b) and
20(a) of the Securities Exchange Act of 1934 and Rule 10b-5,
including allegations of issuing a series of material or false
misrepresentations to the market which had the effect of
artificially inflating the market price during the Class Period,
which is September 23, 2013 through September 7, 2018.
Plaintiff seeks to recover damages on behalf of all Cocrystal
Pharma, Inc., f/k/a BioZone Pharmaceuticals, Inc. shareholders who
purchased common stock during the Class Period and are therefore a
member of the Class as described above. You may move the Court no
later than Monday, November 19, 2018 to serve as a lead plaintiff
for the entire Class. However, in order to do so, you must meet
certain legal requirements pursuant to the Private Securities
Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information
and participate in this or any other securities litigation, or
should you have any questions or concerns regarding this notice or
preservation of your rights, please contact:
Robin HesterFEDERMAN & SHERWOOD10205 North Pennsylvania
AvenueOklahoma City, OK 73120Email to: rkh@federmanlaw.comOr, visit
the firm’s website at www.federmanlaw.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180921005413/en/
Federman & SherwoodRobin Hesterrkh@federmanlaw.com
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cocrystal Pharma (NASDAQ:COCP)
Historical Stock Chart
From Apr 2023 to Apr 2024